The influence of postscreening follow‐up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials
Mengmeng Li(Sun Yat-sen University), Hilary A. Robbins(Centre international de recherche sur le cancer), Evangelia Christodoulou(German Cancer Research Center), Rudolf Kaaks(German Cancer Research Center), Mattias Johansson(Centre international de recherche sur le cancer), Salvatore Vaccarella(Centre international de recherche sur le cancer), Matthew Callister(University of Leeds), Hadrien Charvat(Juntendo University), André Lopes Carvalho(Hospital de Câncer de Barretos), Li Zhang(Centre international de recherche sur le cancer), Peter Sasieni(Queen Mary University of London)
Cited by 15
Related Papers
A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
|New England Journal of Medicine|2019|1.5k
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
|JAMA Dermatology|2022|1.4k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k